about
PD-1 and PD-L1 Expression in NSCLC Indicate a Favorable Prognosis in Defined SubgroupsSpectrum and prognostic relevance of driver gene mutations in acute myeloid leukemia.Molecular codes in biological and chemical reaction networksPotential therapeutic impact of CD13 expression in non-small cell lung cancerMolecular adsorbent recirculating system (MARS) in acute liver injury and graft dysfunction: Results from a case-control studyRule-based modeling and simulations of the inner kinetochore structure.CD8(+) T-cell pathogenicity in Rasmussen encephalitis elucidated by large-scale T-cell receptor sequencing.The histone deacetylase inhibitor SAHA acts in synergism with fenretinide and doxorubicin to control growth of rhabdoid tumor cells.Impact of High-Cut-Off Dialysis on Renal Recovery in Dialysis-Dependent Multiple Myeloma Patients: Results from a Case-Control StudyFactors Associated with Worse Lung Function in Cystic Fibrosis Patients with Persistent Staphylococcus aureus.No evidence for a bovine mastitis Escherichia coli pathotypeThoracic Malignancies and Pulmonary Nodules in Patients under Evaluation for Transcatheter Aortic Valve Implantation (TAVI): Incidence, Follow Up and Possible Impact on Treatment Decision.Patient education in a 14 month randomized trial fails to improve adherence in ulcerative colitis: Influence of demographic and clinical parameters on non-adherence.Evaluation of 131I scintigraphy and stimulated thyroglobulin levels in the follow up of patients with DTC: a retrospective analysis of 1420 patients.Blood group antigen A type 3 expression is a favorable prognostic factor in advanced NSCLC.Rapid Phenotypic Detection of Microbial Resistance in Gram-Positive Bacteria by a Real-Time Laser Scattering Method.Arsenic trioxide-based therapy of relapsed acute promyelocytic leukemia: registry results from the European LeukemiaNet.Infective endocarditis on ICU: risk factors, outcome and long-term follow-up.Treatment strategies in patients with AML or high-risk myelodysplastic syndrome relapsed after Allo-SCT.Prostate specific membrane antigen (PSMA) expression in non-small cell lung cancer.A 29-gene and cytogenetic score for the prediction of resistance to induction treatment in acute myeloid leukemia.CD13 as target for tissue factor induced tumor vascular infarction in small cell lung cancer.PML risk stratification using anti-JCV antibody index and L-selectin.Sex bias in MHC I-associated shaping of the adaptive immune system.Evolution of cytogenetically normal acute myeloid leukemia during therapy and relapse: An exome sequencing study of 50 patients.Use of a Powered Stapling System for Minimally Invasive Lung Volume Reduction Surgery: Results of a Prospective Double-Blind Single-Center Randomized Trial.Direct determination of carbapenem-resistant Enterobacteriaceae and Pseudomonas aeruginosa from positive blood cultures using laser scattering technology.Differentiated thyroid cancer patients more than 60 years old paradoxically show an increased life expectancy.Outcome of allogeneic stem cell transplantation for AML and myelodysplastic syndrome in elderly patients (⩾60 years).Characterization of incisional and inflammatory pain in rats using functional tools of MRI.Staphylococcus aureus in the airways of cystic fibrosis patients - A retrospective long-term study.Prognostic impact of Bcl-2 depends on tumor histology and expression of MALAT-1 lncRNA in non-small-cell lung cancer.Rhesus CE expression on patient red blood cells is an independent prognostic factor for adenocarcinoma of the lung.Clonal heterogeneity of -ITD detected by high-throughput amplicon sequencing correlates with adverse prognosis in acute myeloid leukemiaSequential high-dose cytarabine and mitoxantrone (S-HAM) versus standard double induction in acute myeloid leukemia-a phase 3 studyStromal collagen type VI associates with features of malignancy and predicts poor prognosis in salivary gland cancerSystematic analysis of parameters predicting pathological axillary status (ypN0 vs. ypN+) in patients with breast cancer converting from cN+ to ycN0 through primary systemic therapy (PST)Efficacy and cost-effectiveness of guided and unguided internet- and mobile-based indicated transdiagnostic prevention of depression and anxiety (ICare Prevent): A three-armed randomized controlled trial in four European countriesAn Internet based intervention for improving resilience and coping strategies in university students: Study protocol for a randomized controlled trialInterrelations between participant and intervention characteristics, process variables and outcomes in online interventions: A protocol for overarching analyses within and across seven clinical trials in ICare
P50
Q27853205-EDA5660C-A9DD-4C9B-AC9E-2F0F9A0478B5Q27853390-D0905FCD-407E-4C51-9FA0-27616D4B7154Q28485249-3D8F92A3-3275-4E00-9EE1-32AE727618DAQ30313110-8A0B4D3C-FE4E-4427-AF16-A588F044AA51Q33558782-29E443EB-7574-4C04-8B71-2DE876019081Q34337586-BF12A2B3-7A9E-4886-A3FD-E77D6E10ADC1Q34520675-37D88B97-B19A-4B28-B2F3-8BE57D7531A8Q34771550-DCCC0D8E-DCB7-4FEF-A158-703D93848A10Q36010511-5627CD8D-6889-4442-86C6-1FA5B149B02FQ36197194-E5BE32E9-17F9-43FE-B165-DA8380F1F635Q36366105-65F44AB1-5A4E-4D31-A205-43E13431D161Q36895846-5EF9A2C5-2B9F-41B0-96DB-B44E721BBAF6Q38685956-A4899243-FB74-4CBF-A0DE-3EC922246B02Q38788305-1CED9989-6B96-473D-8472-9049D27784ABQ40099128-488F782F-CF49-46FF-B1E6-5B4361E5C838Q40154205-C4679C3F-7665-4CDD-AD16-4068F865CB51Q41517525-E687936A-FE81-4B98-A66A-197B41BFCE28Q41552725-628FA94F-6BE3-4A9B-A232-4C5B4AEB4FEFQ41564670-C53ABFBB-F805-4614-B286-4010291178C6Q47174885-61EA6198-887B-47BE-BD43-F702D1575CA0Q47307310-79864A33-3E82-4CE8-9BF7-E7449F3B2AB3Q47432352-7B0163B8-8E98-40A2-8ADA-1A517A136279Q48938768-437B8A1A-FA56-46B9-A6F3-82B16550DCB3Q50026558-9325C477-65DF-41E5-A861-F615E8C88585Q50059467-85C0056C-BCE4-4B50-9C18-8190D08C93E8Q50109714-1B5E0461-6C2A-4813-B1D0-6937F614A203Q50125722-E4E13596-08FD-411A-AD18-FDED3195EC9AQ50591491-DCD939D5-96F8-4086-8B77-2D9497F66B5FQ51737769-BE9147F7-FBB5-4244-B7A4-0D4423842BABQ52145564-8388629F-4029-4B71-9413-6A398B7BC94EQ53704862-6C7550B3-19E6-450F-9C81-469500E4AECFQ54198520-F32D6D17-50DD-404E-BC82-02FBFF934D19Q54301102-0B4F066B-655A-4CEC-99BF-D2B3920730A5Q56968572-B82ABFE3-6B9D-4396-813F-04D6EF3BD8C1Q57058964-F5F9FF79-6FBF-48CE-A348-268E5E4A6F78Q57135431-C8960239-8ECF-4144-9D38-C1E28F44A160Q57461922-D77BB69B-36EB-4AC4-AD30-49FF7172B0A3Q60457514-B83B7870-0091-4621-B9A4-CDB9BA7CA69DQ60472706-886A3486-0B3B-43B1-9BEC-AC249783355DQ60635329-F3C5E808-08DB-48DC-8E4A-1C265B608C0A
P50
description
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Dennis Görlich
@ast
Dennis Görlich
@en
Dennis Görlich
@es
Dennis Görlich
@nl
Dennis Görlich
@sl
type
label
Dennis Görlich
@ast
Dennis Görlich
@en
Dennis Görlich
@es
Dennis Görlich
@nl
Dennis Görlich
@sl
prefLabel
Dennis Görlich
@ast
Dennis Görlich
@en
Dennis Görlich
@es
Dennis Görlich
@nl
Dennis Görlich
@sl
P214
P106
P1153
39261410500
P214
P31
P496
0000-0002-2574-9419
P7859
viaf-302156549